CASE REPORT
Published on 10 May 2024
Case report: Massive hepatocellular carcinoma with complete response to the non-surgical systematic treatment strategy
doi 10.3389/fonc.2024.1291131
- 1,231 views
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- New Approaches to Neoadjuvant Therapy and Translational Resection in Hepatobiliary Malignancies
New Approaches to Neoadjuvant Therapy and Translational Resection in Hepatobiliary Malignancies
9,955
Total downloads
27k
Total views and downloads
Articles
REVIEW
Published on 01 Mar 2024
Neoadjuvant systemic therapy for hepatocellular carcinoma
doi 10.3389/fimmu.2024.1355812
- 4,307 views
- 9 citations
REVIEW
Published on 19 Feb 2024
Neoadjuvant Immune Checkpoint Inhibitors in hepatocellular carcinoma: a meta-analysis and systematic review
doi 10.3389/fimmu.2024.1352873
- 3,463 views
- 4 citations
ORIGINAL RESEARCH
Published on 16 Feb 2024
Serum alpha-fetoprotein response as a preoperative prognostic indicator in unresectable hepatocellular carcinoma with salvage hepatectomy following conversion therapy: a multicenter retrospective study
doi 10.3389/fimmu.2024.1308543
- 1,762 views
CASE REPORT
Published on 02 Feb 2024
Case report: From palliative to potentially curative – the advent of immunotherapy providing hope to advanced gallbladder adenocarcinoma
doi 10.3389/fimmu.2024.1353430
- 1,857 views
- 3 citations
ORIGINAL RESEARCH
Published on 15 Jan 2024
Safety and efficacy of biliary stenting combined with iodine-125 seed strand followed by hepatic artery infusion chemotherapy plus lenvatinib with PD-1 inhibitor for the treatment of extrahepatic cholangiocarcinoma with malignant obstructive jaundice
doi 10.3389/fimmu.2023.1286771
- 1,543 views
- 3 citations
ORIGINAL RESEARCH
Published on 08 Jan 2024
Adjuvant immunotherapy improves recurrence-free and overall survival following surgical resection for intermediate/advanced hepatocellular carcinoma a multicenter propensity matching analysis
doi 10.3389/fimmu.2023.1322233
- 2,511 views
- 8 citations
CASE REPORT
Published on 15 Dec 2023
Case report: hepatic arterial infusion chemotherapy combined with sintilimab and lenvatinib for conversion therapy of colorectal cancer liver metastases
doi 10.3389/fimmu.2023.1325445
- 2,077 views
REVIEW
Published on 31 Oct 2023
The worthy role of hepatic arterial infusion chemotherapy in combination with anti-programmed cell death protein 1 monoclonal antibody immunotherapy in advanced hepatocellular carcinoma
doi 10.3389/fimmu.2023.1284937
- 2,571 views
- 9 citations
Published in
Frontiers in Immunology
Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore